Abstract Elevated lipoprotein (a)(Lp [a]) is a causal genetic risk factor for cardiovascular
disease. To determine if current evidence supports both screening and treatment for …

Abstract Purpose of Review The purpose of this article is to review current evidence for
lipoprotein (a)(Lp (a)) as a risk factor for multiple cardiovascular (CV) disease phenotypes …

Lipoprotein (a)[Lp (a)] has enhanced atherothrombotic properties. The ability of Lp (a) levels
to predict adverse cardiovascular outcomes in patients undergoing coronary angiography …

Abstract Lipoprotein (a)(Lp (a)) is a genetically determined causal risk factor for
cardiovascular disease including coronary heart disease, peripheral arterial disease …

There is now significant evidence to support an independent causal role for lipoprotein
(a)(Lp (a)) as a risk factor for atherosclerotic cardiovascular disease. Plasma Lp (a) …

Evidence from Mendelian randomization studies suggest that lipoprotein (a)(Lp (a)) has a
causal role in the development of atherosclerotic cardiovascular disease risk. However …

Aims To investigate the population attributable fraction due to elevated lipoprotein (a)(Lp (a))
and the utility of measuring Lp (a) in cardiovascular disease (CVD) risk prediction. Methods …

Abstract Lipoprotein (a)[Lp (a)] is a well-recognized, independent risk factor for
atherosclerotic cardiovascular disease, with elevated levels estimated to be prevalent in …

Lipoprotein (a)[Lp (a)] is a well-recognized, independent risk factor for atherosclerotic
cardiovascular disease, with elevated levels estimated to be prevalent in 20% of the …

Lipoprotein (a) or lipoprotein “little a”[Lp (a)] is an under-recognized causal risk factor for
cardiovascular (CV) disease (CVD), including coronary atherosclerosis, aortic valvular …